Brief Title
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
Official Title
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
Brief Summary
This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival Secondary purpose: 1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer 2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer
Study Type
Observational [Patient Registry]
Primary Outcome
RFSR
Secondary Outcome
OS
Condition
Cholangiocarcinoma
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
5000
Start Date
August 30, 2019
Completion Date
September 30, 2022
Primary Completion Date
September 30, 2022
Eligibility Criteria
Inclusion Criteria: 1. above the age of 18 years old, male or female 2. clinical diagnosis of patients with cholangiocarcinoma 3. Child-Pugh classification of A, B 4. Eastern Cooperative Oncology Group scoring system (ECOG) score of 0-2 points Exclusion Criteria: - None
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, +86 16601111975, [email protected]
Location Countries
China
Location Countries
China
Administrative Informations
NCT ID
NCT04243057
Organization ID
RWS-BTCH-001
Responsible Party
Principal Investigator
Study Sponsor
Beijing Tsinghua Chang Gung Hospital
Study Sponsor
, ,
Verification Date
January 2020